Psyence Biomedical Ltd. (PBM) - חוב לטווח ארוך להון

This price chart for Psyence Biomedical Ltd. (PBM) illustrates the dynamics of a company whose business relies on non-ferrous metal mining, with a standalone long-term debt figure of 0.00. Canadian transport chains operate stably and without disruption during raw material exploration. However, development in the field of psychedelic medicine is hindered by strict oversight from the DEA and WHO, as well as intense competition from capital-intensive startups.

The high cyclicality of non-ferrous metal mining leaves Psyence Biomedical Ltd. (PBM) vulnerable to commodity volatility. The long-term debt-to-equity ratio measures the proportion of borrowed funds with a maturity of over one year within the financing structure. This coefficient determines the degree of financial autonomy and the risk of bankruptcy in the event of a decline in demand. The metric separates the debt load from the business's own resources. Analyzing the level of long-term liabilities relative to equity allows for an assessment of the issuer's resilience to global crises.